At a glance
ClinicalIndex Comparison RecordN/ACompleted· 66 enrolled
Drug / intervention
JUVÉDERM VOLUMA® XC injectable gel with cannula +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Multicenter, Single-blind, Randomized, Controlled Study of the Safety and Effectiveness of JUVÉDERM VOLUMA® XC Injectable Gel for Cheek Augmentation Using Cannula
In Brief
A clinical study evaluating JUVÉDERM VOLUMA® XC injectable gel with cannula and JUVÉDERM VOLUMA® XC injectable gel with needle for Age-related Volume Deficit in the Mid-face. Completed, enrolled 66 participants across 7 sites.
Detailed Summary
The objective of this study is to evaluate the safety and effectiveness of JUVÉDERM VOLUMA® XC injectable gel using cannula in participants seeking correction of age-related volume deficit in the mid-face.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
Enrollment StartFeb 2018
First PostedFeb 2018
Primary CompletionMay 2018
Study CompletionAug 2018
TodayJul 2026
First PostedFeb 19, 2018
Enrollment StartFeb 5, 2018
Primary CompletionMay 29, 2018
Study CompletionAug 2, 2018
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 8.4 years ago
Interventions
JUVÉDERM VOLUMA® XC injectable gel with cannuladevice
Participants had 1 cheek treated with JUVÉDERM VOLUMA® XC injectable gel with cannula.
JUVÉDERM VOLUMA® XC injectable gel with needledevice
Participants had 1 cheek treated with JUVÉDERM VOLUMA® XC injectable gel with a needle.